HMOX1 and pachyonychia congenita: Similarly, the inhibition of HO-1 or direct interference with HO-1 metabolites may be a new strategy for PC treatment, as HO-1 inhibition or iron chelation in human PC cell lines has increased the sensitivity and susceptibility to chemotherapy in an in vivo model 200.